As of 2024-07-27, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 121.25 USD. This relative valuation is based on P/E multiples. With the latest stock price at 146.80 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is -17.4%.
The range of the Relative Valuation is 93.88 - 169.57 USD.
| Range | Selected | |
| Trailing P/E multiples | 34.6x - 46.2x | 40.0x |
| Forward P/E multiples | 31.3x - 33.7x | 31.9x |
| Fair Price | 93.88 - 169.57 | 121.25 |
| Upside | -36.0% - 15.5% | -17.4% |
| Date | P/E |
| 2024-07-26 | 39.96 |
| 2024-07-25 | 39.77 |
| 2024-07-24 | 39.71 |
| 2024-07-23 | 39.59 |
| 2024-07-22 | 39.55 |
| 2024-07-19 | 39.66 |
| 2024-07-18 | 39.24 |
| 2024-07-17 | 39.38 |
| 2024-07-16 | 40.14 |
| 2024-07-15 | 40.14 |
| 2024-07-12 | 40.13 |
| 2024-07-11 | 39.88 |
| 2024-07-10 | 40.05 |
| 2024-07-09 | 39.01 |
| 2024-07-08 | 38.72 |
| 2024-07-05 | 37.86 |
| 2024-07-03 | 37.63 |
| 2024-07-02 | 37.43 |
| 2024-07-01 | 38.14 |
| 2024-06-28 | 37.48 |
| 2024-06-27 | 36.56 |
| 2024-06-26 | 36.98 |
| 2024-06-25 | 36.77 |
| 2024-06-24 | 36.37 |
| 2024-06-21 | 36.63 |
| 2024-06-20 | 36.50 |
| 2024-06-18 | 35.62 |
| 2024-06-17 | 36.83 |
| 2024-06-14 | 36.87 |
| 2024-06-13 | 37.09 |
| 2024-06-12 | 36.65 |
| 2024-06-11 | 36.25 |
| 2024-06-10 | 36.67 |
| 2024-06-07 | 36.74 |
| 2024-06-06 | 36.22 |
| 2024-06-05 | 36.39 |
| 2024-06-04 | 36.34 |
| 2024-06-03 | 38.09 |
| 2024-05-31 | 36.86 |
| 2024-05-30 | 37.20 |
| 2024-05-29 | 36.65 |
| 2024-05-28 | 38.24 |
| 2024-05-24 | 37.95 |
| 2024-05-23 | 38.25 |
| 2024-05-22 | 37.96 |
| 2024-05-21 | 38.26 |
| 2024-05-20 | 38.56 |
| 2024-05-17 | 38.73 |
| 2024-05-16 | 38.63 |
| 2024-05-15 | 38.66 |